Start-up RallyBio Inc., which launched on April 25 with $37m in Series A venture capital, is starting out with a dream team of executives with experience developing, launching and marketing therapies for rare diseases.
The Farmington, Conn.-based company was founded in January by three former Alexion Pharmaceuticals Inc. executives: Martin Mackay, Stephen Uden...






